Residual cardiovascular risk beyond LDL-C in ASCVD: Biological drivers, biomarkers, and therapeutic strategies

Ke Gong, Junming Tang, Viktoria Stanislavovna Berestovskaya, Teppo Heimo, Hao Wang, Hui Huang, Yajun Duan
Acta Pharmaceutica Sinica B · Elsevier · 2026-11-01 · DOI: 10.1016/j.apsb.2026.11.011

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles